Tuesday, May 08, 2007

Medical case reports serve a vital role in medicine....Case studies provide unique insights into the rare side effects of new medications, early warning indicators of potential new diseases, unexpected associations between diseases or symptoms, and much more. Indeed, it was through case reports in the medical literature, that the earliest information on AIDS, Lyme disease and toxic shock syndrome emerged.

In recent years, however, economic and ethical pressures have led research journals to publish fewer and fewer medical case reports. The main pressure seems to be that such papers are of limited interest when read in isolation and more problematic from the publishers’ point of view are unlikely to be highly cited. Many research journals tout citation counts as a major selling point both to authors and subscribers, so poor-selling papers are unattractive to the marketing team.

The end result, is that a vast wealth of unique scientific data is simply lost.

Michael Kidd, Professor and Head of the Discipline of General Practice at the University of Sydney, hopes to change all that. He is founder of the open access (OA) Journal of Medical Case Reports. The OA approach taken by this journal means that medical case reports can find an audience regardless of citation concerns. By utilizing the OA publishing model, interesting case reports can reach the medical profession where previously they would simply sink without trace. With open access to this information, doctors can easily compare symptoms and treatments between patients and researchers and can sift through thousands of reports to formulate hypotheses and search for patterns and correlations. Who knows when the next AIDS or Lyme disease will emerge. Case reports might provide the first hints from the unfortunate “early adopters.”

Posted by
Peter Suber at 5/08/2007 11:14:00 PM.

The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.